Why this status
- 17 Jun 2020: Trial registered, NCT04435587
- 13 Jul 2020: Trial started, NCT04435587
The trials
NCT04435587: Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection
- State
- State not given
- Phase
- Phase 4
- People
- 80 planned
- Started
- 13 Jul 2020
- Primary completion
- Jun 2021
- Arms
- ivermectin
- Results
- None posted
- 17 Jun 2020: Trial registered
- 13 Jul 2020: Trial started
How the status changed
- 19 Nov 2026: First set: Phase 3 trial
About the treatment
Kind of treatment: Drug.
Also known as Acarexx, Bimectin, Bovinet, Cardomec, CARDOTEK 30, Cevamec, Equimec, Eqvalan, Heartgard, Hyvermectin, Ivectin, IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care., Ivertin, Ivomec, Ivosint, Ivermectin (IVM), Ivermectin 0.4mg/kg/day for 5 days, Ivermectin 3 MG, Ivermectin 3mg Tab, Ivermectin Injectable Product, Ivermectin Oral Product, Ivermectin Pill, Ivermectin Tablets, Ivermectin Topical, Ivermectin nasal, Ivermectin oral, Jetamec, Mectizan, Noramectin, Noromectin, Oramec, Pandex, Phoenectin, Sklice, Soolantra, Stromectol, Uvemec, Vermic, Vetmec, Zimecterin, intranasal ivermectin spray.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.